ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

RGT Argent Biopharma Limited

6.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.00 5.00 7.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Holding(s) in Company

16/07/2003 8:00am

UK Regulatory


RNS Number:5958N
ReGen Therapeutics PLC
16 July 2003


ReGen Therapeutics Plc
Embargoed until 7am 16 July 2003


ReGen Therapeutics Plc


SUBSTANTIAL SHAREHOLDING


London, UK - 16 May, 2003: ReGen Therapeutics Plc (the "Company") announces that
on 15 July 2003 it received notification from Mr Colin Blackbourn that he is
beneficially interested in 7,000,000 ordinary shares of the Company representing
3.1% of the current issued share capital of the Company.


For further information, please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLEAXXSFDLDEFE

1 Year Argent Biopharma Chart

1 Year Argent Biopharma Chart

1 Month Argent Biopharma Chart

1 Month Argent Biopharma Chart